Article Text

Download PDFPDF
083 Facial twitching, breathlessness and fever: an unexpected and potentially lethal triad
  1. Gashirai K Mbizvo1,2,
  2. Isabel Lentell3,
  3. Clifford Leen4,
  4. Huw Roddie5,
  5. Chris Derry2,
  6. Susan Duncan2,1,
  7. Kristiina Rannikmäe6
  1. 1Muir Maxwell Epilepsy Centre, Centre for Clinical Brain Sciences, The University of Edinburgh
  2. 2Department for Clinical Neurosciences, Western General Hospital, Edinburgh
  3. 3Haematology, Cambridge University Hospitals NHS Foundation Trust, Cambridge
  4. 4Regional Infectious Diseases Unit, Western General Hospital, Edinburgh
  5. 5Department of Haematology, Western General Hospital, Edinburgh
  6. 6Forth Valley Royal Hospital, Larbert


Background We describe a patient co-presenting with epilepsia partialis continua (EPC), disseminated tuberculosis (TB), and hemophagocytic lymphohistiocytosis (HLH).

Case A 54-year-old lady presented with facial twitching, breathlessness, and night sweats. Clinical examination revealed pyrexia and continuous, stereotyped, right-sided facial contractions. These worsened with speech and continued through sleep. A clinical diagnosis of EPC was made (video provided). CT imaging of the chest and serous fluid analyses were consistent with a diagnosis of disseminated Mycobacterium tuberculosis, with a left motor strip tuberculoma evident on post-contrast MRI brain. An additional diagnosis of HLH was made following the identification of pancytopenia and hyperferritinaemia on peripheral blood, with hemophagocytosis evident on bone marrow investigation (pathology slides provided). She was extremely unwell and hospitalised for six months, including two admissions to intensive care for invasive ventilation. She was treated successfully with high doses of antiepileptic drugs, 12 months of oral anti-TB therapy, and chemotherapy with eight weeks of etoposide and dexamethasone for HLH, followed by 12 months of ciclosporin and prednisolone.

Conclusions Presentation with this triad is rare – to our knowledge, this is the first documented case. A lack of evidence surrounding the co-expression of this triad may represent absolute rarity or, more likely, clinical failure to recognise the triad (resulting in early death from untreated TB/HLH). Therefore, the case helps improve education around how such a patient may present and be managed.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.